Philip Morris seals contentious Vectura takeover
16th Sep 2021 08:02
(Sharecast News) - Philip Morris International has taken control of Vectura after the cigarette company's contentious bid was supported by owners of almost 75% of the inhaler maker's shares.
Read morePhilip Morris snaps up more Vectura shares ahead of deal deadline
19th Aug 2021 14:32
(Sharecast News) - US tobacco giant Philip Morris has bought up more shares of London-listed inhaler maker Vectura.
Read morePhilip Morris buys 22.6% stake in Vectura as experts warn against deal
18th Aug 2021 09:51
(Sharecast News) - US tobacco giant Philip Morris International bought a 22.6% stake in London-listed inhaler-maker Vectura, as health experts warned investors not to approve a takeover.
Read morePhilip Morris wins takeover battle for inhaler maker Vectura
12th Aug 2021 17:13
(Sharecast News) - US tobacco giant Philip Morris has won the battle for London-listed inhaler maker Vectura.
Read moreCarlyle says Vectura offer is final, paves way for PMI
11th Aug 2021 07:59
(Sharecast News) - US tobacco giant Philip Morris looks set to potentially clinch the deal for Vectura after rival suitor Carlyle said it would not be upping its offer for the London-listed inhaler maker.
Read morePhilip Morris switches Vectura scheme of arrangement to takeover offer
10th Aug 2021 09:16
(Sharecast News) - Philip Morris has switched its bid for London-listed inhaler maker Vectura to a takeover offer from a scheme of arrangement, which means the US tobacco giant will now require a lower level of shareholder approval.
Read moreBattle for Vectura could go to auction as Philip Morris lifts bid
9th Aug 2021 08:44
(Sharecast News) - Vecura has withdrawn its intention to recommend the sweetened offer made by Carlyle at the end of last week after an increased offer from Philip Morris, as the UK Takeover Panel said the process would be put to auction if both suitors don't make final bids by Tuesday.
Read moreCarlyle sweetens offer for Vectura, trumps Philip Morris
6th Aug 2021 16:40
(Sharecast News) - Vectura shares surged on Friday after private equity firm Carlyle upped its offer for the inhaler maker to £958m, trumping an earlier offer from US tobacco giant Philip Morris International.
Read moreCarlyle given more time to consider Vectura offer
4th Aug 2021 13:30
(Sharecast News) - Private equity firm Carlyle said on Wednesday that it has been given more time consider whether to go ahead with an offer for Vectura, after it agreed to be bought by US tobacco company Philip Morris in a £1bn deal.
Read moreSunday newspaper roundup: Vectura, Sunak, Cobham
18th Jul 2021 11:35
(Sharecast News) - "The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a healthcare company, claiming that the acquisition will help achieve its target to make the UK smoke-free within a decade. In the wake of fierce opposition to the deal to buy FTSE 250 inhaler-maker Vectura, André Calantzopoulos, PMI's executive chairman, said the "obsessive focus" by anti-smoking campaigners on Big Tobacco was the "wrong approach", adding that PMI has the "ability and the technology" to address harm from smoking." - Sunday Telegraph
Read morePhilip Morris swoops for Vectura Group with £1bn bid
9th Jul 2021 07:02
(Sharecast News) - Tobacco giant Philip Morris on Friday swooped for UK pharmaceuticals company Vectura Group with a £1.045bn recommended offer.
Read moreVectura to be taken over by Carlyle in £958m deal
26th May 2021 07:56
(Sharecast News) - Pharmaceutical company Vectura said on Wednesday that it has agreed to be taken over by US private equity firm The Carlyle Group in a £958m deal, sending the shares sharply higher.
Read moreRoyalty income, litigation win see Vectura beat expectations
18th Mar 2021 07:43
(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.
Read moreVectura delays results because of KPMG staff shortage
5th Mar 2021 12:29
(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.
Read moreVectura reports 'strong' operational performance in 2020
12th Jan 2021 08:16
(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.
Read more